SlideShare a Scribd company logo
1 of 56
Adequacy Criteria for
Cytology Specimens
Mahra Nourbakhsh, MD, PhD
Resident Physician, PGY-3
Anatomical Pathology
What is an adequate sample?
Disappointing and Confusing!!
• Technique (FNA, Brushing, Washing, Exfoliation, etc.)
• Operator (Clinician, Surgeon, Radiologist, Pathologist)
• Organ
• Type of lesion (Solid, Cystic, Solid/Cystic)
• Pathology: (Non/Neoplastic, Malignant, Benign,
inflammatory)
• Complexity of the pathology (Tumor with dual
differentiation, carcinosarcoma, warthine tumor, etc.)
• Preparation, processing, staining
• Patient’s condition (age, gender, history, clinical
findings)
There is no simple answer
False Negative & False Positive
Representative Sample
Normal Lesion
• Webster’s Dictionary: sufficient in quality
and/or quantity to satisfy one’s needs.
• Bethesda System: Appropriate labeling and
identifying information; Relevant clinical information;
Adequate numbers (a compilation from the literature)
of well-preserved and well-visualized representative
component cells
• My approach to adequacy: When there is
discordance in clinical, radiologic and cytology
findings, the adequacy of the specimen is
questionable.
What is an adequate sample?
Uterine Cervix
• A consensus on adequacy of cervical
smear has been reached however the
adequacy should still be considered
case by case.
• Variable:
1. Obscuring Element
2. Minimum Squamous Cellularity
3. Presence of Transformational Zone
(absence does not automatically indicates
unsatisfactory specimen)
Uterine Cervix
Obscuring Elements
•Elements:
– Blood
– Inflammation
– Necrotic artifacts
•If covers more than 75% of epithelial
cells unsat
Uterine Cervix
Minimum Squamous Cellularity
•Liquid Base
– At least 5000 squamous cells
– Metaplastic squamous cell are acceptable
– Endocervical and Endometrial cells are not
included.
•Conventional
– At least 8000-12000 squamous cells
– Metaplastic squamous cell are acceptable
– Endocervical and Endometrial cells are not
included.
Uterine Cervix
Presence of T Zone
•T-Zone:
– At least 10 well-preserved endocervical or
squamous metaplastic cells singly or in
cluster
•Absence of T-Zone does not automatically
classifies the specimen as unsatisfactory.
•Report if T-zone present or absent.
Uterine Cervix
35F TAH 2°to a benign
condition
Estimated cells of 5000-10000
Hysterectomy
Uterine Cervix
56F TAH 2°to Endometrial CA Estimated cells of 5000-10000
Hysterectomy
Uterine Cervix
56F with pelvic radiation Estimated cells of 5000-10000
Hysterectomy
Uterine Cervix
46F with recent chemotherapy Estimated cells of 5000-10000
Hysterectomy
Uterine Cervix
Does reduction of cellularity from 8000 to 2000 is
wise in post chemotherapy, post pelvic radiation or
hysterectomy?
Lu Ch, et. Al. Cancer Cytopathol. 2010;118 (6):474-81
•7059 pap, 1361 had Hx of pelvic radiotherapy,
chemotherapy and hysterectomy.
•Results:
•No increase in false-negative rate
•Hysterectomy does not significantly correlates with
unsatisfactory Pap
Unsat Criteria <8000 <2000
Post Radiotherapy 17.9% 7.6%
Post Chemotherapy 19.6% 6%
Respiratory Tract (Sputum)
• Guideline of Pap Society of
Cytopathology Task Force
Mod Path. 1999; 12 (4): 427-436
1. Must contain alveolar macrophages
2. No numerical cut point for macrophages,
but should be easily identifiable
3. Should be large enough to prepare at least
2-4 slides.
4. Sensitivity to diagnose malignancy increase
from 42% with a single specimen to 91%
with five specimen.
Respiratory Tract
(washing and brushing)
• Guideline of Pap Society of
Cytopathology Task Force
Mod Path. 1999; 12 (4): 427-436
1. Large number of (not exactly defined), well-
preserved, optimally stained ciliated
bronchial epithelial cells and macrophages.
2. Should not be heavily contaminated with
oral squamous cells or saprophytes
3. Absence of obscuring elements.
Respiratory Tract (BAL)
• Guideline of Pap Society of Cytopathology Task
Force
Mod Path. 1999; 12 (4): 427-436
1. >5% of ciliated or squamous epithelial cells 
contamination of distal airways.
2. Chamberlain et.al criteria of inadequacy:
Chamberline DW, et. Al. Acta Cytol 1987;31:599-605
• Less than 10 alveolar mac/ 10 hpf
• Less than 25 alveolar mac/10hpf and one of the
followings:
– Excessive epithelial cells with degenerative features or
exceeding number of macs
– Mucopurulent exudate of PMN
• Numerous obscuring RBC
• Degenerative changes or artifact obscuring cell
identity
Respiratory Tract (FNA)
• Guideline of Pap Society of
Cytopathology Task Force
Mod Path. 1999; 12 (4): 427-436
1. Complex issue
2. No universally acceptable criteria in the
absence of abnormality.
3. Depends on procedure, operator skills and
location and size of the lesion.
4. The findings are insufficient to account for
the lesion
5. Use non-diagnostic rather than Unsat
Respiratory Tract
• 65 M smoker, 5 cm speculated mass, BAL
Too Much Text
Urine and Bladder
• Usefulness of the specimen to
diagnose or broach the suspicion of
urothelial carcinoma.
• Is determined by the interplay of:
1. Collection type
2. Cellularity
3. Volume
4. Cytomorphological findings
Urine and Bladder
• Limited publication on the role and and
specific qualifiers of collection type,
cellularity, and volume.
• Adequacy algorithm based on Paris system
recommendation:
1. The communication between volume, collection
type and cellularity.
2. Guide for individual labs in validating appropriate
cut-offs for their own practice settings
3. Frame the future investigations dealing with
adequacy of urine specimen
Urine and Bladder
Cellularity
Collection Type
Volume
Urine and Bladder: Cellularity
Instrumental Urinary Specimen
1.Sat: 20 well-preserved, well-visualized. Urothelial cells per 10
high-power fields.
2.Sat but limited by low cellularity: 10-20 cells
3.Unsat: <10 cells
Prather J, Arville B, Chatt G, et al. J Am Soc Cytopathol. 2015;4:57-62
•1322 urothelial cells (10 per 10 hpfs) for diagnosis of atypical
urothelial cells and above.
Prather J, et. al. J Am Soc Cytopathol. 2013; 2: S24-S25
1.2644 urothelial cells (20 per 10 hpfs) in the absence of
atypical cells or higher to increase the positive predictive value
of this test.
Prather J, Arville B, Chatt G, et al. J Am Soc Cytopathol. 2015;4:57-62
Urine and Bladder: Cellularity
Voided Urine Specimen
1.No paper in literature review
investigating the cellularity required for
adequacy in voided urine specimen.
2.However two studies suggest cell
counts for surveillance but are older
studies (>80 urothelial cells/hpf?!).
Morse N, et. al. Acta Cytol 1974: 18:312–315
Murphy WM, et. al. J Urol 1981:126:320–322.
Urine and Bladder: Volume
• At least 30 ml of urine is required in voided
urine samples.
VandenBussche CJ, et. al. Cancer Cytopathol. 2016;124:174-180
1. Indication of voided urine cytology were not
provided.
2. SurePath method.
• The Paris system recommendation shows
two microscope-dependent nodes precede
volume in the adequacy algorithm:
1. finding of atypical, suspicious, or malignant cells
2. an adequate number of benign urothelial cells
Fluids (Pleural, Pericardial, Peritoneal)
• Adequacy have no role in providing
procurement information.
• Adequacy have a role in identifying
processing problem.
• In the absence of abnormality or
acellular fluid, no criteria has been
indicated for adequacy.
Crothers, BA. Et al. Arch Pathol Lab Med. 2009 Nov;133(11):1743-56
Peritoneal Wash
• In the absence of abnormal cells
presence of mesothelial cells is
recommended for reporting a
specimen adequate.
McGowan L. et. Al. Obstet. Gynecol. 1989;73:136-137
• No consensus is reached for
adequacy of washes.
CSF
• Adequacy have no
role in providing
procurement
information. It is
based on how much
the lesion exfoliates.
• No consensus has
reached
My dog shed
GI Tract (FNA)
• An adequate is one that explain the
clinical/endoscopic findings.
• It is reasonable to consider a FNA
adequate if there is sufficient cellularity to
suggest limited DDX or explain the
clinical/radiologic findings.
• Scant cellularity, obscuring elements,
poorly preserved samples are the reasons
for unsatisfactory aspirates
•
GI Tract (Brushing)
• No consensus is reached regarding
adequacy.
• An adequate brushing is one with 6-10 well-
visualized and well-preserved epithelial cell
groups (at least 6 cells/cluster).
• Too few cells, poor preservation, degenerated
cells, obscuring elements render the
specimen unsatisfactory
Moody Dr. CAP Today. August 2003, pp 68-70
Breast
• Two opposite views toward the
adequacy
• An epithelial cell cluster (ECC) cut
off number for adequacy
• Non cellular features such as type of
the lesion instead of ECC cut off
number
Breast
• Study #1: 4455 FNA, 51 false negative
in MD Anderson Cancer Institute from
1985-1995.
Boerner S., and Sneige N. Cancer 1998; 84: pp. 344-348
– Criteria: 6 ECCs on all slides for a
sample to be classified as adequate,
– Results: 50% of the false-negative
was avoided.
presence ≥ 10 intact bipolar cells per 10 medium-
power fields (×200),
Breast
• Study #2: 1779 FNA, 21 false negative
in Duke University Medical Center
(1992-1995) and UCLA Center for the
Health Sciences (1984-1990).
Boerner S., and Sneige N. Cancer 1998; 84: pp. 344-348
– Criteria: 6 ECCs or >10 bipolar cells in
each of medium power field (X200) on all
slides for a sample to be classified as
adequate,
– Results: False negative rate 1.5% and
unsat ratio of 20.2%.
Layfield L.J., Mooney E.E. et. al. Cancer 1997; 81: pp. 16-21
Breast
• F32 with no FHx of breast malignancy
with a Cystic Lesion at 10 O’clock,
measuring 3.2 cm in largest dimension
presence ≥ 10 intact bipolar cells per 10 medium-
power fields (×200),
Breast
• F52 with a Solid mass at 7 O’clock,
measuring 1.8 cm in largest dimension
presence ≥ 10 intact bipolar cells per 10 medium-
power fields (×200)
Breast (conclusion)
• No consensus reached.
• For suspected epithelial lesion, 6 epithelial
cell cluster of 5-10 cells each reduces the
false negativity.
• For non-epithelial lesion no minimal cell
group is proposed.
• Use of triple test is highly recommended.
• No consensus reached for nipple
discharge cytology
Thyroid
• Minimum six group of well preserved , well
visualized follicular cells
• Each group contains a minimum of 10 cells.
• Preferably all six groups are on same slide
• Fewer follicular cell groups may be
accepted if there is abundance of
lymphocytes, granulomas or colloid.
Thyroid
Thyroid
• F43 with a cystic nodule at inferior pole
of Lt. thyroid, measuring 2.8 cm
presence ≥ 10 intact bipolar cells per 10
medium-power fields (×200)
Thyroid
• F39 with a cystic nodule at superior
pole of Rt. thyroid, measuring 2.9 cm
presence ≥ 10 intact bipolar cells per 10
medium-power fields (×200)
Thyroid
• 6 months later
Salivary Gland
• Adequacy criteria has not been established yet.
• The rate of false negative is related to type of
lesion, the operator (Cytopathologist, vs.
Radiologist vs. Surgeon).
• False negative results are most common with
low-grade mucoepidermoid carcinoma, adenoid
cystic carcinoma, and non-Hodgkin lymphoma
• False-positive diagnoses are seen with cystic
lesions, particularly WT and pleomorphic
adenoma (PA).
Salivary Gland
• Experience of UPMC: 294 case from 1999-
2012, with FNA and then surgical specimen
obtained within 6 months.
Griffith CC, et. al, AM J Clin Pathol. 2015 Jun;143(6):839-53
• Adequacy Criteria: 4 hpf (×400) of epithelial
cells
• Results: 28.2% inadequacy rate, including
38.6% non-neoplastic, 43.4% benign and 18.1%
malignant including one case of high grade.
• Results: Specificity for pleomorphic adenoma
98.8% but sensitivity only 58.2%
Lymph Node
• FNA of any lymph node: at least a
moderate number of lymphocytes
must be present.
• Well preserved, well visualized
lymphocyte is required.
• Based on the location of the lymph
node the adequate sample might
be difficult to obtained.
Lymph Node (mediastinum)
• Rapid On-Site Evaluation of FNA
and Core Needle Biopsy
Choi, SM. et. Al. Ann Thorac Surg. 2016 Feb;101(2):444-50
• Using four sequential criteria, tissue core
size, the presence of malignant cell,
microscopic anthracotic pigments, and
LD ‡40 cells/field, the sensitivity and
accuracy rates increased from 64.4% to
98.6% and from 64.7% to 97.3%,
respectively.
Kidney
• Up to 30% of renal aspirates are
non-diagnostic (inadequate)
• Repeat aspiration is helpful in 50% of
case.
• Technical failure is number one
reason for inadequacy.
• No consensus on adequacy criteria
Kidney
• Analysis of Results and Diagnostic Problem in
108 FNA of Renal Masses in Adult.
Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349
Adequacy criteria in solid lesion:
• Unsat:
1. soft tissue and/or normal kidney tissue only
2. Blood or necrotic material only
3. Technically poor
4. Scant cellularity: smear contains few cells or small cluster,
the nature of which cannot determined.
• Sat:
1. Large number of well-preserved, isolated or cell clusters,
which allow at least limited DDX
Kidney
• Analysis of Results and Diagnostic Problem in
108 FNA of Renal Masses in Adult.
Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349
Adequacy criteria in cystic lesion:
• Unsat:
1. soft tissue and/or normal kidney tissue only
2. Blood or necrotic material only
• Sat:
1. Fluid regardless of cellularity
Kidney
• Analysis of Results and Diagnostic Problem in
108 FNA of Renal Masses in Adult.
Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349
Results:
1. The rate of unsat was 16% in lesion containing
solid compartment and 0% in cystic lesion
2. Only one false negative case (out of 34) judged
benign while later biopsy showed malignant
RCC.
Kidney
• 72M with a cystic renal lesion
Kidney
Current recommendation:
•No consensus, however it is reasonable to
consider a FNA adequate if there is
sufficient cellularity to suggest limited DDX.
•Specimen composed exclusively
macrophages (typically cystic lesion) is
best reported as non-diagnostic as cystic
RCC can not be ruled out.
Adrenal Gland, Ovary
and Deep Solid Organs
• No Standard consensus.
• Similar to Kidney (and other deep solid
organs), presence of sufficient
cellularity to suggest limited DDXs.
• Scant cellularity, obscuring elements,
poorly preserved samples are the
reasons for unsatisfactory aspirates.
Conclusion
• There is no simple/single criteria for
adequacy
• Adequacy should remain in the
discretion of cytopathologists even in the
organ system with a defined adequacy
criteria
• Clinical, radiologic and cytopathologic
findings remain the most important
factors for determining adequacy criteria
Thank you!
Question/Discussion?!

More Related Content

What's hot

QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNG
QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNGQUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNG
QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNGSoM
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardstriumphbenelux
 
International Innovation
International InnovationInternational Innovation
International InnovationKevin Fowler
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Aieme Uam
 
20160219 - F. Grati - Toma - Maternal Malignancies
20160219 - F. Grati - Toma - Maternal Malignancies20160219 - F. Grati - Toma - Maternal Malignancies
20160219 - F. Grati - Toma - Maternal MalignanciesRoberto Scarafia
 
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...Cirdan
 
Prostate carcinoma- clinical trial
Prostate  carcinoma- clinical trialProstate  carcinoma- clinical trial
Prostate carcinoma- clinical trialGovtRoyapettahHospit
 
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...QIAGEN
 
Austin Journal of Clinical & Diagnostic Research
Austin Journal of Clinical & Diagnostic ResearchAustin Journal of Clinical & Diagnostic Research
Austin Journal of Clinical & Diagnostic ResearchAustin Publishing Group
 

What's hot (17)

Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...
Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...
Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote ...
 
Karyometry Identifies a Distinguishing Fallopian Tube Epithelium Phenotype in...
Karyometry Identifies a Distinguishing Fallopian Tube Epithelium Phenotype in...Karyometry Identifies a Distinguishing Fallopian Tube Epithelium Phenotype in...
Karyometry Identifies a Distinguishing Fallopian Tube Epithelium Phenotype in...
 
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
 
QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNG
QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNGQUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNG
QUẢN LÝ KẾT QUẢ BẤT THƯỜNG TEST TẦM SOÁT UNG THƯ CỔ TỬ CUNG
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standards
 
International Innovation
International InnovationInternational Innovation
International Innovation
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
20160219 - F. Grati - Toma - Maternal Malignancies
20160219 - F. Grati - Toma - Maternal Malignancies20160219 - F. Grati - Toma - Maternal Malignancies
20160219 - F. Grati - Toma - Maternal Malignancies
 
Journal club
Journal clubJournal club
Journal club
 
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...
Peter Hamilton on Next generation Imaging and Computer Vision in Pathology: p...
 
Prostate carcinoma- clinical trial
Prostate  carcinoma- clinical trialProstate  carcinoma- clinical trial
Prostate carcinoma- clinical trial
 
Cancer of Unknown Primary
Cancer of Unknown PrimaryCancer of Unknown Primary
Cancer of Unknown Primary
 
5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests
 
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...
The Molecular Analysis on Circulating Tumor Cells to Determine Prognostic and...
 
Austin Journal of Clinical & Diagnostic Research
Austin Journal of Clinical & Diagnostic ResearchAustin Journal of Clinical & Diagnostic Research
Austin Journal of Clinical & Diagnostic Research
 
Brain metastasis
Brain metastasisBrain metastasis
Brain metastasis
 

Viewers also liked (9)

Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
Mahra Nourbakhsh's presentation, Hepatitis C Virus #1Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
 
Hepatitis C Presentation for CHOW 2011
Hepatitis C Presentation for CHOW 2011Hepatitis C Presentation for CHOW 2011
Hepatitis C Presentation for CHOW 2011
 
Viral hepatitis c. corrected
Viral hepatitis c. correctedViral hepatitis c. corrected
Viral hepatitis c. corrected
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
Hepatitis C Presentation 2014
Hepatitis C Presentation 2014 Hepatitis C Presentation 2014
Hepatitis C Presentation 2014
 
Hepatitis C and its Treatment
Hepatitis C and its TreatmentHepatitis C and its Treatment
Hepatitis C and its Treatment
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
 

Similar to Adequacy criteria for cytology specimens by Mahra Nourbakhsh

BETHESDA SYSTEM.pptx
BETHESDA SYSTEM.pptxBETHESDA SYSTEM.pptx
BETHESDA SYSTEM.pptxGice3
 
Indeterminate biliary stricture
Indeterminate biliary strictureIndeterminate biliary stricture
Indeterminate biliary strictureMahesh Raj
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
 
Bethesda system for cervix cytology
Bethesda system for cervix cytologyBethesda system for cervix cytology
Bethesda system for cervix cytologyRavi Kumar Meena
 
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptxROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptxNirupama kothari
 
C&E news talk sept 16
C&E news talk sept 16C&E news talk sept 16
C&E news talk sept 16Sean Ekins
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...ES-Teck India
 
03 Asc H Medicolegal Austin
03 Asc H  Medicolegal  Austin03 Asc H  Medicolegal  Austin
03 Asc H Medicolegal Austinvshidham
 
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...European School of Oncology
 
Investigations & Evaluation of Male partner after 2 IUI failure
Investigations & Evaluation of Male partner after 2 IUI failureInvestigations & Evaluation of Male partner after 2 IUI failure
Investigations & Evaluation of Male partner after 2 IUI failureSujoy Dasgupta
 
Pap Smear: A Bird's Eye View from a Cytopathologist
Pap Smear: A Bird's Eye View from a CytopathologistPap Smear: A Bird's Eye View from a Cytopathologist
Pap Smear: A Bird's Eye View from a CytopathologistDr. Shubhi Saxena
 
JOURNAL CLUB 14-03-2022.pptx
JOURNAL CLUB 14-03-2022.pptxJOURNAL CLUB 14-03-2022.pptx
JOURNAL CLUB 14-03-2022.pptxJyotiSharma560718
 
Understanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment OptionsUnderstanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment Optionsbkling
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationSandro Esteves
 

Similar to Adequacy criteria for cytology specimens by Mahra Nourbakhsh (20)

BETHESDA SYSTEM.pptx
BETHESDA SYSTEM.pptxBETHESDA SYSTEM.pptx
BETHESDA SYSTEM.pptx
 
Indeterminate biliary stricture
Indeterminate biliary strictureIndeterminate biliary stricture
Indeterminate biliary stricture
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Bethesda system for cervix cytology
Bethesda system for cervix cytologyBethesda system for cervix cytology
Bethesda system for cervix cytology
 
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptxROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
ROLE_OF_CERVICAL_CYTOLOGY_IN_SCREENING.pptx
 
C&E news talk sept 16
C&E news talk sept 16C&E news talk sept 16
C&E news talk sept 16
 
Is the Paris System Sufficient for Reporting Urinary Cytology?
Is the Paris System Sufficient for Reporting Urinary Cytology?Is the Paris System Sufficient for Reporting Urinary Cytology?
Is the Paris System Sufficient for Reporting Urinary Cytology?
 
Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears ...
Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears ...Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears ...
Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears ...
 
Liverpool uemseflm2014
Liverpool uemseflm2014Liverpool uemseflm2014
Liverpool uemseflm2014
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
 
03 Asc H Medicolegal Austin
03 Asc H  Medicolegal  Austin03 Asc H  Medicolegal  Austin
03 Asc H Medicolegal Austin
 
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...
MCO 2011 - Slide 35 - F. Blackhall - Spotlight session - Circulating tumour c...
 
main.pdf
main.pdfmain.pdf
main.pdf
 
Investigations & Evaluation of Male partner after 2 IUI failure
Investigations & Evaluation of Male partner after 2 IUI failureInvestigations & Evaluation of Male partner after 2 IUI failure
Investigations & Evaluation of Male partner after 2 IUI failure
 
RH_pap_test.ppt
RH_pap_test.pptRH_pap_test.ppt
RH_pap_test.ppt
 
Cell block and its utility
Cell block and its utilityCell block and its utility
Cell block and its utility
 
Pap Smear: A Bird's Eye View from a Cytopathologist
Pap Smear: A Bird's Eye View from a CytopathologistPap Smear: A Bird's Eye View from a Cytopathologist
Pap Smear: A Bird's Eye View from a Cytopathologist
 
JOURNAL CLUB 14-03-2022.pptx
JOURNAL CLUB 14-03-2022.pptxJOURNAL CLUB 14-03-2022.pptx
JOURNAL CLUB 14-03-2022.pptx
 
Understanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment OptionsUnderstanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment Options
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
 

More from Mahra Nourbakhsh

Adequacy criteria for cytology specimens by Dr. Mahra Nourbakhsh
Adequacy criteria for cytology specimens by Dr. Mahra NourbakhshAdequacy criteria for cytology specimens by Dr. Mahra Nourbakhsh
Adequacy criteria for cytology specimens by Dr. Mahra NourbakhshMahra Nourbakhsh
 
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...Mahra Nourbakhsh
 
Dr. Mahra Nourbakhsh's Presentation, Inflammation and Repair
Dr. Mahra Nourbakhsh's Presentation, Inflammation and RepairDr. Mahra Nourbakhsh's Presentation, Inflammation and Repair
Dr. Mahra Nourbakhsh's Presentation, Inflammation and RepairMahra Nourbakhsh
 
Mahra Nourbakhsh's poster, Hepatitis C Virus #3
Mahra Nourbakhsh's poster, Hepatitis C Virus #3Mahra Nourbakhsh's poster, Hepatitis C Virus #3
Mahra Nourbakhsh's poster, Hepatitis C Virus #3Mahra Nourbakhsh
 
Mahra Nourbakhsh's presentation, hepatitis C virus #2
Mahra Nourbakhsh's presentation, hepatitis C virus #2Mahra Nourbakhsh's presentation, hepatitis C virus #2
Mahra Nourbakhsh's presentation, hepatitis C virus #2Mahra Nourbakhsh
 
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory System
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory SystemMahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory System
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory SystemMahra Nourbakhsh
 

More from Mahra Nourbakhsh (6)

Adequacy criteria for cytology specimens by Dr. Mahra Nourbakhsh
Adequacy criteria for cytology specimens by Dr. Mahra NourbakhshAdequacy criteria for cytology specimens by Dr. Mahra Nourbakhsh
Adequacy criteria for cytology specimens by Dr. Mahra Nourbakhsh
 
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...
Dr. Mahra Nourbakhsh: The Involvement of Diacylglycerol Acyltransferase (DGAT...
 
Dr. Mahra Nourbakhsh's Presentation, Inflammation and Repair
Dr. Mahra Nourbakhsh's Presentation, Inflammation and RepairDr. Mahra Nourbakhsh's Presentation, Inflammation and Repair
Dr. Mahra Nourbakhsh's Presentation, Inflammation and Repair
 
Mahra Nourbakhsh's poster, Hepatitis C Virus #3
Mahra Nourbakhsh's poster, Hepatitis C Virus #3Mahra Nourbakhsh's poster, Hepatitis C Virus #3
Mahra Nourbakhsh's poster, Hepatitis C Virus #3
 
Mahra Nourbakhsh's presentation, hepatitis C virus #2
Mahra Nourbakhsh's presentation, hepatitis C virus #2Mahra Nourbakhsh's presentation, hepatitis C virus #2
Mahra Nourbakhsh's presentation, hepatitis C virus #2
 
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory System
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory SystemMahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory System
Mahra Nourbakhsh's Lecture for Pathology Assistants, Respiratory System
 

Recently uploaded

Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...narwatsonia7
 
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...Miss joya
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...narwatsonia7
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 

Recently uploaded (20)

Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
 
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...
VIP Call Girls Pune Sanjana 9907093804 Short 1500 Night 6000 Best call girls ...
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 

Adequacy criteria for cytology specimens by Mahra Nourbakhsh

  • 1. Adequacy Criteria for Cytology Specimens Mahra Nourbakhsh, MD, PhD Resident Physician, PGY-3 Anatomical Pathology
  • 2. What is an adequate sample? Disappointing and Confusing!!
  • 3. • Technique (FNA, Brushing, Washing, Exfoliation, etc.) • Operator (Clinician, Surgeon, Radiologist, Pathologist) • Organ • Type of lesion (Solid, Cystic, Solid/Cystic) • Pathology: (Non/Neoplastic, Malignant, Benign, inflammatory) • Complexity of the pathology (Tumor with dual differentiation, carcinosarcoma, warthine tumor, etc.) • Preparation, processing, staining • Patient’s condition (age, gender, history, clinical findings) There is no simple answer
  • 4. False Negative & False Positive
  • 6. • Webster’s Dictionary: sufficient in quality and/or quantity to satisfy one’s needs. • Bethesda System: Appropriate labeling and identifying information; Relevant clinical information; Adequate numbers (a compilation from the literature) of well-preserved and well-visualized representative component cells • My approach to adequacy: When there is discordance in clinical, radiologic and cytology findings, the adequacy of the specimen is questionable. What is an adequate sample?
  • 7. Uterine Cervix • A consensus on adequacy of cervical smear has been reached however the adequacy should still be considered case by case. • Variable: 1. Obscuring Element 2. Minimum Squamous Cellularity 3. Presence of Transformational Zone (absence does not automatically indicates unsatisfactory specimen)
  • 8. Uterine Cervix Obscuring Elements •Elements: – Blood – Inflammation – Necrotic artifacts •If covers more than 75% of epithelial cells unsat
  • 9. Uterine Cervix Minimum Squamous Cellularity •Liquid Base – At least 5000 squamous cells – Metaplastic squamous cell are acceptable – Endocervical and Endometrial cells are not included. •Conventional – At least 8000-12000 squamous cells – Metaplastic squamous cell are acceptable – Endocervical and Endometrial cells are not included.
  • 10. Uterine Cervix Presence of T Zone •T-Zone: – At least 10 well-preserved endocervical or squamous metaplastic cells singly or in cluster •Absence of T-Zone does not automatically classifies the specimen as unsatisfactory. •Report if T-zone present or absent.
  • 11. Uterine Cervix 35F TAH 2°to a benign condition Estimated cells of 5000-10000 Hysterectomy
  • 12. Uterine Cervix 56F TAH 2°to Endometrial CA Estimated cells of 5000-10000 Hysterectomy
  • 13. Uterine Cervix 56F with pelvic radiation Estimated cells of 5000-10000 Hysterectomy
  • 14. Uterine Cervix 46F with recent chemotherapy Estimated cells of 5000-10000 Hysterectomy
  • 15. Uterine Cervix Does reduction of cellularity from 8000 to 2000 is wise in post chemotherapy, post pelvic radiation or hysterectomy? Lu Ch, et. Al. Cancer Cytopathol. 2010;118 (6):474-81 •7059 pap, 1361 had Hx of pelvic radiotherapy, chemotherapy and hysterectomy. •Results: •No increase in false-negative rate •Hysterectomy does not significantly correlates with unsatisfactory Pap Unsat Criteria <8000 <2000 Post Radiotherapy 17.9% 7.6% Post Chemotherapy 19.6% 6%
  • 16. Respiratory Tract (Sputum) • Guideline of Pap Society of Cytopathology Task Force Mod Path. 1999; 12 (4): 427-436 1. Must contain alveolar macrophages 2. No numerical cut point for macrophages, but should be easily identifiable 3. Should be large enough to prepare at least 2-4 slides. 4. Sensitivity to diagnose malignancy increase from 42% with a single specimen to 91% with five specimen.
  • 17. Respiratory Tract (washing and brushing) • Guideline of Pap Society of Cytopathology Task Force Mod Path. 1999; 12 (4): 427-436 1. Large number of (not exactly defined), well- preserved, optimally stained ciliated bronchial epithelial cells and macrophages. 2. Should not be heavily contaminated with oral squamous cells or saprophytes 3. Absence of obscuring elements.
  • 18. Respiratory Tract (BAL) • Guideline of Pap Society of Cytopathology Task Force Mod Path. 1999; 12 (4): 427-436 1. >5% of ciliated or squamous epithelial cells  contamination of distal airways. 2. Chamberlain et.al criteria of inadequacy: Chamberline DW, et. Al. Acta Cytol 1987;31:599-605 • Less than 10 alveolar mac/ 10 hpf • Less than 25 alveolar mac/10hpf and one of the followings: – Excessive epithelial cells with degenerative features or exceeding number of macs – Mucopurulent exudate of PMN • Numerous obscuring RBC • Degenerative changes or artifact obscuring cell identity
  • 19. Respiratory Tract (FNA) • Guideline of Pap Society of Cytopathology Task Force Mod Path. 1999; 12 (4): 427-436 1. Complex issue 2. No universally acceptable criteria in the absence of abnormality. 3. Depends on procedure, operator skills and location and size of the lesion. 4. The findings are insufficient to account for the lesion 5. Use non-diagnostic rather than Unsat
  • 20. Respiratory Tract • 65 M smoker, 5 cm speculated mass, BAL
  • 22. Urine and Bladder • Usefulness of the specimen to diagnose or broach the suspicion of urothelial carcinoma. • Is determined by the interplay of: 1. Collection type 2. Cellularity 3. Volume 4. Cytomorphological findings
  • 23. Urine and Bladder • Limited publication on the role and and specific qualifiers of collection type, cellularity, and volume. • Adequacy algorithm based on Paris system recommendation: 1. The communication between volume, collection type and cellularity. 2. Guide for individual labs in validating appropriate cut-offs for their own practice settings 3. Frame the future investigations dealing with adequacy of urine specimen
  • 25. Urine and Bladder: Cellularity Instrumental Urinary Specimen 1.Sat: 20 well-preserved, well-visualized. Urothelial cells per 10 high-power fields. 2.Sat but limited by low cellularity: 10-20 cells 3.Unsat: <10 cells Prather J, Arville B, Chatt G, et al. J Am Soc Cytopathol. 2015;4:57-62 •1322 urothelial cells (10 per 10 hpfs) for diagnosis of atypical urothelial cells and above. Prather J, et. al. J Am Soc Cytopathol. 2013; 2: S24-S25 1.2644 urothelial cells (20 per 10 hpfs) in the absence of atypical cells or higher to increase the positive predictive value of this test. Prather J, Arville B, Chatt G, et al. J Am Soc Cytopathol. 2015;4:57-62
  • 26. Urine and Bladder: Cellularity Voided Urine Specimen 1.No paper in literature review investigating the cellularity required for adequacy in voided urine specimen. 2.However two studies suggest cell counts for surveillance but are older studies (>80 urothelial cells/hpf?!). Morse N, et. al. Acta Cytol 1974: 18:312–315 Murphy WM, et. al. J Urol 1981:126:320–322.
  • 27. Urine and Bladder: Volume • At least 30 ml of urine is required in voided urine samples. VandenBussche CJ, et. al. Cancer Cytopathol. 2016;124:174-180 1. Indication of voided urine cytology were not provided. 2. SurePath method. • The Paris system recommendation shows two microscope-dependent nodes precede volume in the adequacy algorithm: 1. finding of atypical, suspicious, or malignant cells 2. an adequate number of benign urothelial cells
  • 28. Fluids (Pleural, Pericardial, Peritoneal) • Adequacy have no role in providing procurement information. • Adequacy have a role in identifying processing problem. • In the absence of abnormality or acellular fluid, no criteria has been indicated for adequacy. Crothers, BA. Et al. Arch Pathol Lab Med. 2009 Nov;133(11):1743-56
  • 29. Peritoneal Wash • In the absence of abnormal cells presence of mesothelial cells is recommended for reporting a specimen adequate. McGowan L. et. Al. Obstet. Gynecol. 1989;73:136-137 • No consensus is reached for adequacy of washes.
  • 30. CSF • Adequacy have no role in providing procurement information. It is based on how much the lesion exfoliates. • No consensus has reached My dog shed
  • 31. GI Tract (FNA) • An adequate is one that explain the clinical/endoscopic findings. • It is reasonable to consider a FNA adequate if there is sufficient cellularity to suggest limited DDX or explain the clinical/radiologic findings. • Scant cellularity, obscuring elements, poorly preserved samples are the reasons for unsatisfactory aspirates •
  • 32. GI Tract (Brushing) • No consensus is reached regarding adequacy. • An adequate brushing is one with 6-10 well- visualized and well-preserved epithelial cell groups (at least 6 cells/cluster). • Too few cells, poor preservation, degenerated cells, obscuring elements render the specimen unsatisfactory Moody Dr. CAP Today. August 2003, pp 68-70
  • 33. Breast • Two opposite views toward the adequacy • An epithelial cell cluster (ECC) cut off number for adequacy • Non cellular features such as type of the lesion instead of ECC cut off number
  • 34. Breast • Study #1: 4455 FNA, 51 false negative in MD Anderson Cancer Institute from 1985-1995. Boerner S., and Sneige N. Cancer 1998; 84: pp. 344-348 – Criteria: 6 ECCs on all slides for a sample to be classified as adequate, – Results: 50% of the false-negative was avoided. presence ≥ 10 intact bipolar cells per 10 medium- power fields (×200),
  • 35. Breast • Study #2: 1779 FNA, 21 false negative in Duke University Medical Center (1992-1995) and UCLA Center for the Health Sciences (1984-1990). Boerner S., and Sneige N. Cancer 1998; 84: pp. 344-348 – Criteria: 6 ECCs or >10 bipolar cells in each of medium power field (X200) on all slides for a sample to be classified as adequate, – Results: False negative rate 1.5% and unsat ratio of 20.2%. Layfield L.J., Mooney E.E. et. al. Cancer 1997; 81: pp. 16-21
  • 36. Breast • F32 with no FHx of breast malignancy with a Cystic Lesion at 10 O’clock, measuring 3.2 cm in largest dimension presence ≥ 10 intact bipolar cells per 10 medium- power fields (×200),
  • 37. Breast • F52 with a Solid mass at 7 O’clock, measuring 1.8 cm in largest dimension presence ≥ 10 intact bipolar cells per 10 medium- power fields (×200)
  • 38. Breast (conclusion) • No consensus reached. • For suspected epithelial lesion, 6 epithelial cell cluster of 5-10 cells each reduces the false negativity. • For non-epithelial lesion no minimal cell group is proposed. • Use of triple test is highly recommended. • No consensus reached for nipple discharge cytology
  • 39. Thyroid • Minimum six group of well preserved , well visualized follicular cells • Each group contains a minimum of 10 cells. • Preferably all six groups are on same slide • Fewer follicular cell groups may be accepted if there is abundance of lymphocytes, granulomas or colloid.
  • 41. Thyroid • F43 with a cystic nodule at inferior pole of Lt. thyroid, measuring 2.8 cm presence ≥ 10 intact bipolar cells per 10 medium-power fields (×200)
  • 42. Thyroid • F39 with a cystic nodule at superior pole of Rt. thyroid, measuring 2.9 cm presence ≥ 10 intact bipolar cells per 10 medium-power fields (×200)
  • 44. Salivary Gland • Adequacy criteria has not been established yet. • The rate of false negative is related to type of lesion, the operator (Cytopathologist, vs. Radiologist vs. Surgeon). • False negative results are most common with low-grade mucoepidermoid carcinoma, adenoid cystic carcinoma, and non-Hodgkin lymphoma • False-positive diagnoses are seen with cystic lesions, particularly WT and pleomorphic adenoma (PA).
  • 45. Salivary Gland • Experience of UPMC: 294 case from 1999- 2012, with FNA and then surgical specimen obtained within 6 months. Griffith CC, et. al, AM J Clin Pathol. 2015 Jun;143(6):839-53 • Adequacy Criteria: 4 hpf (×400) of epithelial cells • Results: 28.2% inadequacy rate, including 38.6% non-neoplastic, 43.4% benign and 18.1% malignant including one case of high grade. • Results: Specificity for pleomorphic adenoma 98.8% but sensitivity only 58.2%
  • 46. Lymph Node • FNA of any lymph node: at least a moderate number of lymphocytes must be present. • Well preserved, well visualized lymphocyte is required. • Based on the location of the lymph node the adequate sample might be difficult to obtained.
  • 47. Lymph Node (mediastinum) • Rapid On-Site Evaluation of FNA and Core Needle Biopsy Choi, SM. et. Al. Ann Thorac Surg. 2016 Feb;101(2):444-50 • Using four sequential criteria, tissue core size, the presence of malignant cell, microscopic anthracotic pigments, and LD ‡40 cells/field, the sensitivity and accuracy rates increased from 64.4% to 98.6% and from 64.7% to 97.3%, respectively.
  • 48. Kidney • Up to 30% of renal aspirates are non-diagnostic (inadequate) • Repeat aspiration is helpful in 50% of case. • Technical failure is number one reason for inadequacy. • No consensus on adequacy criteria
  • 49. Kidney • Analysis of Results and Diagnostic Problem in 108 FNA of Renal Masses in Adult. Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349 Adequacy criteria in solid lesion: • Unsat: 1. soft tissue and/or normal kidney tissue only 2. Blood or necrotic material only 3. Technically poor 4. Scant cellularity: smear contains few cells or small cluster, the nature of which cannot determined. • Sat: 1. Large number of well-preserved, isolated or cell clusters, which allow at least limited DDX
  • 50. Kidney • Analysis of Results and Diagnostic Problem in 108 FNA of Renal Masses in Adult. Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349 Adequacy criteria in cystic lesion: • Unsat: 1. soft tissue and/or normal kidney tissue only 2. Blood or necrotic material only • Sat: 1. Fluid regardless of cellularity
  • 51. Kidney • Analysis of Results and Diagnostic Problem in 108 FNA of Renal Masses in Adult. Truong, LD. et. Al. Diagnostic Cytopathol; 1999;20(6):339-349 Results: 1. The rate of unsat was 16% in lesion containing solid compartment and 0% in cystic lesion 2. Only one false negative case (out of 34) judged benign while later biopsy showed malignant RCC.
  • 52. Kidney • 72M with a cystic renal lesion
  • 53. Kidney Current recommendation: •No consensus, however it is reasonable to consider a FNA adequate if there is sufficient cellularity to suggest limited DDX. •Specimen composed exclusively macrophages (typically cystic lesion) is best reported as non-diagnostic as cystic RCC can not be ruled out.
  • 54. Adrenal Gland, Ovary and Deep Solid Organs • No Standard consensus. • Similar to Kidney (and other deep solid organs), presence of sufficient cellularity to suggest limited DDXs. • Scant cellularity, obscuring elements, poorly preserved samples are the reasons for unsatisfactory aspirates.
  • 55. Conclusion • There is no simple/single criteria for adequacy • Adequacy should remain in the discretion of cytopathologists even in the organ system with a defined adequacy criteria • Clinical, radiologic and cytopathologic findings remain the most important factors for determining adequacy criteria

Editor's Notes

  1. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  2. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  3. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  4. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  5. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  6. Adequacy of urine specimens for the diagnosis of urothelial carcinoma is determined by the interplay of four specimen characteristics
  7. MD Anderson 1985-1995
  8. MD Anderson 1985-1995
  9. MD Anderson 1985-1995
  10. MD Anderson 1985-1995
  11. MD Anderson 1985-1995
  12. NCI criteria
  13. NCI criteria
  14. MD Anderson 1985-1995
  15. MD Anderson 1985-1995
  16. MD Anderson 1985-1995